Your browser doesn't support javascript.
loading
Impact of sex on the assessment of the microvascular resistance reserve.
Boerhout, Coen K M; Vink, C E M; Lee, Joo Myung; de Waard, Guus A; Mejia-Renteria, Hernan; Lee, Seung Hun; Jung, Ji-Hyun; Hoshino, Masahiro; Echavarria-Pinto, Mauro; Meuwissen, Martijn; Matsuo, Hitoshi; Madera-Cambero, Maribel; Eftekhari, Ashkan; Effat, Mohamed A; Murai, Tadashi; Marques, Koen; Doh, Joon-Hyung; Christiansen, Evald H; Banerjee, Rupak; Nam, Chang-Wook; Niccoli, Giampaolo; Nakayama, Masafumi; Tanaka, Nobuhiro; Shin, Eun-Seok; Appelman, Yolande; Beijk, Marcel A M; van Royen, Niels; Chamuleau, Steven A J; Knaapen, Paul; Escaned, Javier; Kakuta, Tsunekazu; Koo, Bon Kwon; Piek, Jan J; van de Hoef, Tim P.
Afiliação
  • Boerhout CKM; Heart Center, Amsterdam UMC, Amsterdam, the Netherlands.
  • Vink CEM; Heart Center, Amsterdam UMC, Amsterdam, the Netherlands.
  • Lee JM; Samsung Medical Center, Sungkyunkwan University School of Medicine, Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Seoul, Republic of Korea.
  • de Waard GA; Heart Center, Amsterdam UMC, Amsterdam, the Netherlands.
  • Mejia-Renteria H; Hospital Clínico San Carlos, IDISSC, and Universidad Complutense de Madrid, Madrid, Spain.
  • Lee SH; Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Republic of Korea.
  • Jung JH; Sejong General Hospital, Sejong Heart Institute, Bucheon, Republic of Korea.
  • Hoshino M; Gifu Heart Center, Department of Cardiovascular Medicine, Gifu, Japan.
  • Echavarria-Pinto M; Hospital General ISSSTE Querétaro - Facultad de Medicina, Universidad Autónoma de Querétaro, Querétaro, Mexico.
  • Meuwissen M; Department of Cardiology, Amphia Hospital, Breda, the Netherlands.
  • Matsuo H; Gifu Heart Center, Department of Cardiovascular Medicine, Gifu, Japan.
  • Madera-Cambero M; Tergooi Hospital, Department of Cardiology, Blaricum, the Netherlands.
  • Eftekhari A; Aarhus University Hospital, Department of Cardiology, Aarhus, Denmark.
  • Effat MA; Division of Cardiovascular Health and Diseases, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA.
  • Murai T; Tsuchiura Kyodo General Hospital, Department of Cardiology, Tsuchiura City, Japan.
  • Marques K; Heart Center, Amsterdam UMC, Amsterdam, the Netherlands.
  • Doh JH; Department of Medicine, Inje University Ilsan Paik Hospital, Goyang, South Korea.
  • Christiansen EH; Aarhus University Hospital, Department of Cardiology, Aarhus, Denmark.
  • Banerjee R; Mechanical and Materials Engineering Department, University of Cincinnati Cincinnati, OH, USA; Research Services, Veteran Affairs Medical Center, Cincinnati, OH, USA.
  • Nam CW; Department of Medicine, Keimyung University, Daegu, South Korea.
  • Niccoli G; Catholic University of the Sacred Heart, Department of Cardiovascular Medicine, Institute of Cardiology, Rome, Italy.
  • Nakayama M; Gifu Heart Center, Department of Cardiovascular Medicine, Gifu, Japan; Toda Central General Hospital, Cardiovascular Center, Toda, Japan.
  • Tanaka N; Tokyo Medical University Hachioji Medical Center, Department of Cardiology, Tokyo, Japan.
  • Shin ES; Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
  • Appelman Y; Heart Center, Amsterdam UMC, Amsterdam, the Netherlands.
  • Beijk MAM; Heart Center, Amsterdam UMC, Amsterdam, the Netherlands.
  • van Royen N; Department of Cardiology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Chamuleau SAJ; Heart Center, Amsterdam UMC, Amsterdam, the Netherlands.
  • Knaapen P; Heart Center, Amsterdam UMC, Amsterdam, the Netherlands.
  • Escaned J; Hospital Clínico San Carlos, IDISSC, and Universidad Complutense de Madrid, Madrid, Spain.
  • Kakuta T; Tsuchiura Kyodo General Hospital, Department of Cardiology, Tsuchiura City, Japan.
  • Koo BK; Seoul National University Hospital, Department of Internal Medicine, Cardiovascular Center, Seoul, Republic of Korea.
  • Piek JJ; Heart Center, Amsterdam UMC, Amsterdam, the Netherlands.
  • van de Hoef TP; Department of Cardiology, University Medical Centre Utrecht, the Netherlands. Electronic address: t.p.vandehoef@umcutrecht.nl.
Int J Cardiol ; 402: 131832, 2024 May 01.
Article em En | MEDLINE | ID: mdl-38316189
ABSTRACT

BACKGROUND:

The microvascular resistance reserve (MRR) is an innovative index to assess the vasodilatory capacity of the coronary circulation while accounting for the presence of concomitant epicardial disease. The MRR has shown to be a valuable diagnostic and prognostic tool in the general coronary artery disease (CAD) population. However, considering the fundamental aspects of its assessment and the unique hemodynamic characteristics of women, it is crucial to provide additional considerations for evaluating the MRR specifically in women.

AIM:

The aim of this study was to assess the diagnostic and prognostic applicability of the MRR in women and assess the potential differences across different sexes.

METHODS:

From the ILIAS Registry, we enrolled all patients with a stable indication for invasive coronary angiography, ensuring complete physiological and follow-up data. We analyzed the diagnostic value by comparing differences between sexes and evaluated the prognostic value of the MRR specifically in women, comparing it to that in men.

RESULTS:

A total of 1494 patients were included of which 26% were women. The correlation between MRR and CFR was good and similar between women (r = 0.80, p < 0.005) and men (r = 0.81, p < 0.005). The MRR was an independent and important predictor of MACE in both women (HR 0.67, 0.47-0.96, p = 0.027) and men (HR 0.84, 0.74-0.95, p = 0.007). The optimal cut-off value for MRR in women was 2.8 and 3.2 in men. An abnormal MRR similarly predicted MACE at 5-year follow-up in both women and men.

CONCLUSION:

The MRR seems to be equally applicable in both women and men with stable coronary artery disease.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Reserva Fracionada de Fluxo Miocárdico Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Reserva Fracionada de Fluxo Miocárdico Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article